"phase 3 study on a life extending Cancer treatment with high likelihood of success"
Yet they could not find a partner or funding? Well funding that wasn't toxic? Pharmas shell out billions for promising drugs but not for slam dunk cancer drug that would have cost them 10-20M?
Uplist is not going to happen way things are. For one they don't even meet MC requirements. With OS likely in 300M+ range within few months how are they going meet min price requirements? There is no way this is going to $1.5 BILLION market cap on pink sheets. They'd have to do another massive reverse split. Price would crash again and they would have trouble meeting MC requirement.
Also they are burning through cash fast. They'll need to raise again. Which will end with this stock where its been last couple months as all old shareholder value will get wiped out again. Just got to hope note holders sell out quick enough and give this some time to bounce without a huge selling ceiling overhead.